To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4417 | Rhlr Agonist S4 |
Quorum sensing modulator as a RhlR agonist
More description
|
|
| DCC4416 | Rhizoxin |
Potent tubulin assembly and cancer cell growth inhibitor
More description
|
|
| DCC4415 | Rh-5849 |
Novel Insect growth regulator, as potential insecticide to control olive fruit fly (Bactrocera oleae Rossi)
More description
|
|
| DCC4414 | Rh02007 |
Novel inhibitor of the human papillomavirus (HPV) E6 oncoprotein
More description
|
|
| DCC4413 | rh01617 |
Potent inhibitor of Kv1.5 potassium channel
More description
|
|
| DCC4412 | Rgia-5524 |
Novel Potent and Stable Antagonist of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain
More description
|
|
| DCC4411 | rgh-237 |
Orally active, selective dopamine D3 receptor partial agonist
More description
|
|
| DCC4410 | Rgd-ss-ca |
Novel peptide-drug conjugate, inducing significant tumor growth suppression with negligible toxicity
More description
|
|
| DCC4409 | Rgd-mimetic-1 |
Novel avß6 selective arginyl-glycinyl-aspartic acid (RGD)-mimetic, demonstrating to bind with extremely high affinity and selectivity for the alphavß6 integrin and having the potential as a clinical tool and therapeutic for investigating the role of avß6
More description
|
|
| DCC4408 | Rgb-286147 |
Potent, selective & ATP-competitive inhibitor of Cdks
More description
|
|
| DCC4407 | Rg7388-tco |
Highly Potent Clickable Probe for Cellular Imaging of MDM2 and Assessing Dynamic Responses to MDM2-p53 Inhibition
More description
|
|
| DCC4406 | Rg-102240 |
Gene switch ligand as a transcription inducer for use in induceable gene expression systems
More description
|
|
| DCC4405 | Rf470dl |
Novel fluorescent D-amino acid for labeling peptidoglycans (PG) in live bacteria
More description
|
|
| DCC4404 | Rf3286 |
Novel Highly Selective Neuropeptide FF1 Receptor Antagonist, Potently Preventing Opioid-Induced Hyperalgesia
More description
|
|
| DCC4403 | Rf04289 |
Novel TLR2 activator
More description
|
|
| DCC4402 | Reveromycins Inducer Br-1 |
Novel biomediator that induces reveromycins production at the wide range of concentrations without affecting cell growth
More description
|
|
| DCC4401 | Revamilast |
Novel phosphodiesterase IV (PDE4) inhibitor for the treatment of Asthma and Rheumatoid Arthritis
More description
|
|
| DCC4400 | Rev1/ubm2 Inhibitor |
Novel inhibitor of the REV1/UbPCNA interaction, directly binding to REV1 UBM2 and preventing DNA damage tolerance (DDT)
More description
|
|
| DCC4399 | Retro-2.1 |
Novel potent inhibitor of EBOV infection and entry
More description
|
|
| DCC4398 | Resveratrol-4’-sulfate |
Metabolite of Resveratrol
More description
|
|
| DCC4397 | resveratrol-3-sulfate |
Metabolite of Resveratrol
More description
|
|
| DCC4396 | Resorufin-r1 |
Red-absorbing, water-soluble, and iodinated resorufin derivative, being selectively activated with a monoamine oxidase (MAO) enzyme, showing high 1O 2 generation yields in aqueous solutions upon addition of MAO isoforms
More description
|
|
| DCC4395 | Resorcinolnaphthalein |
Angiotensin-converting enzyme 2 (ACE2) activator, acting as a modulator on RAAS and KKS activation during COVID-19
More description
|
|
| DCC4394 | Resiniferatoxin |
Potent VR1 vanilloid receptor agonist, activating protein kinase C
More description
|
|
| DCC4393 | Resazurin |
Oxidation-reduction indicator in cell viability
More description
|
|
| DCC4392 | Repinotan Hydrochloride |
Selective 5-HT1A receptor agonist
More description
|
|
| DCC4391 | Rep8839 |
Novel bacterial methionyl t-RNA synthetase (MRS) inhibitor, hampering Plasmodium growth very effectively
More description
|
|
| DCC4390 | Renzapride Hydrochloride |
5-HT3 antagonist and 5-HT4 agonist, also acting as a 5-HT2B antagonist
More description
|
|
| DCC4389 | Remifentanil |
Potent ultra short-acting synthetic unique opioid analgesic
More description
|
|
| DCC4388 | Remeglurant |
Novel selective antagonist of the mGlu5 receptor
More description
|
|